Drs. Ondrej Choutka, MD, a neurosurgeon, and Lindsay Sales, MD, a radiation oncologist at Saint Alphonsus Regional Medical Center in Boise, have become the first doctors in the Pacific Northwest to utilize a new treatment for brain tumors. They implanted the FDA-cleared GammaTile therapy in a 44-year-old patient with a malignant brain tumor.
Surgeons at Henry Ford Health System have treated a patient with a recurrent brain tumor by delivering a dose of radiation directly to the cancer inside the brain, a novel approach that could delay or prevent future tumor cells from regrowing.
Mayfield Brain & Spine, the region’s premier neurosurgery practice, announced that the first patients have been enrolled in a new clinical trial to investigate GammaTile® targeted therapy to treat newly diagnosed metastatic brain tumors.
GT Medical Technologies, Inc. today announced it was named a winner of the Innovator of the Year in the small company category at the 2021 Governor’s Celebration of Innovation, presented live on stage by the Arizona Technology Council and the Arizona Commerce Authority on October 13.
GT Medical Technologies, Inc. today announced it is presenting clinical data in two oral presentations on the company’s breakthrough GammaTile® Therapy for patients with brain tumors at the 2021 American Association of Neurological Surgeons (AANS) Annual Scientific Meeting.
This press release announces a trial collaboration between Novocure and GT Medical Technologies to develop Tumor Treating Fields (TTFields) together with GammaTile Therapy for the treatment of recurrent GBMs. Tumor Treating Fields are electric fields that disrupt cancer cell division. The study will evaluate the effectiveness and safety of adjuvantly using TTFields prior to resection + GammaTile, with progression free survival (PFS) for the ITT population being the primary endpoint.
GT Medical Technologies announces it has been honored by AZ Big Media with a 2021 Healthcare Leadership Award in the Healthcare Innovators of the Year category, which recognizes the best and the brightest in healthcare in Arizona.
An AdventHealth neurosurgeon and radiation oncologist became the first team in Central Florida to use a new and potentially life-extending technology called GammaTile during brain surgery for cancer patients.
A University Hospitals Cleveland Medical Center neurosurgeon is among the first in the region to begin offering GammaTile® Therapy, a new approach to treating brain tumors.
Illustrating the expanded use of its innovative GammaTile® Therapy treatment for newly diagnosed malignant and recurrent brain tumors across the U.S., GT Medical Technologies Inc. today announced its 2020 roster of ELITE Distinguished Brain Tumor Specialists that have completed 10 or more GammaTile Therapy procedures in 2020.
